2 papers
National Institute on AgingUS$7.1m
Multifocal transcranial current stimulation for cognitive and motor dysfunction in dementia
National Institute on AgingHebrew Rehabilitation Center for AgedUS$1.6m2022–2027
Vascular contribution to white matter lesions and motor dysfunction in AD and ADRD
National Institute on AgingRutgers Biomedical and Health SciencesUS$1.2m2022–2027
Multifocal transcranial current stimulation for cognitive and motor dysfunction in dementia
National Institute on AgingHebrew Rehabilitation Center for AgedUS$759.3k2022–2025
In mice with severe mitochondrial disease, a two-drug treatment extended median lifespan from 62 days to 158 days.In mice with severe mitochondrial disease, a two-drug treatment extended median lifespan from 62 days to 158 days.